Kentuckiana Pulmonary Associates

Louisville, Kentucky 40202

Use our guide to learn which trials are right for you!

We've found
16 trials
at this facility
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.
Status: Enrolling, Phase II
Updated: 10/29/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Enrolling, Phase II
Updated: 12/10/2013
mi
from
Louisville, KY
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling, Phase III
Updated: 9/2/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
Status: Enrolling, Phase III
Updated: 12/14/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling, Phase III
Updated: 9/2/2015
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
ACT-293987 in Pulmonary Arterial Hypertension
Status: Enrolling, Phase III
Updated: 1/13/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Early Diagnosis of Pulmonary Nodules
Status: Enrolling
Updated: 1/26/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 3/1/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Status: Enrolling, Phase III
Updated: 3/1/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinical Trial
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Idiopathic Pulmonary Fibrosis Clinical Trial
A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling, Phase II
Updated: 3/3/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument
Status: Enrolling, Phase III
Updated: 3/1/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
Status: Enrolling, Phase III
Updated: 3/16/2016
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
Status: Enrolling
Updated: 1/20/2016
mi
from
Louisville, KY
Click here to add this to my saved trials